Characterization and clinical implications of marker chromosomes identified at prenatal diagnosis

✍ Scribed by Marilyn M. Li; Patricia N. Howard-Peebles; Lillian D. Killos; Lee Fallon; Eileen Listgarten; Wayne S. Stanley

• Publisher: John Wiley and Sons
• Year: 2000
• Tongue: English
• Weight: 111 KB
• Volume: 20
• Category: Article
• ISSN: 0197-3851
• DOI: 10.1002/(sici)1097-0223(200002)20:2<138::aid-pd772>3.0.co;2-2

✦ Synopsis

Eighteen fetuses with marker chromosomes were detected at diagnostic amniocentesis in our laboratory among 15 781 amniocentesis samples. Using combined approaches, conventional cytogenetics including special stain techniques and ¯uorescence in situ hybridization (FISH), we successfully characterized 15 of them, which assisted subsequent genetic counselling. Six marker chromosomes were of sex chromosome origin, each of which substituted a missing sex chromosome, and 12 were supernumerary marker chromosomes (SMCs). Nine of the SMCs were proven to be of autosomal origin. Of those autosomal SMCs, ®ve originated from chromosome 15, two from chromosome 18, one from chromosome 12 and one from chromosome 1. Among 16 marker chromosomes with adequate follow-up information, 50% were benign including four sex chromosome markers and four autosomal markers. Two thirds of de novo marker chromosomes were associated with abnormal outcomes, while all inherited ones were benign regardless of their parental origin. Our study demonstrated that molecular characterization of prenatal marker chromosomes is of great signi®cance in facilitating phenotype±genotype correlation.